Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

HIV-1 antibody serum negativity with urine positivity.

Urnovitz HB, Clerici M, Shearer GM, Gottfried TD, Robison DJ, Lutwick LI, Montagnier L, Landers DV.

Lancet. 1993 Dec 11;342(8885):1458-9.

PMID:
7902483
2.

Increased sensitivity of HIV-1 antibody detection.

Urnovitz HB, Sturge JC, Gottfried TD.

Nat Med. 1997 Nov;3(11):1258.

PMID:
9359701
3.

Detection of antibody IgG to HIV-1 in urine by sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using recombinant proteins as antigens for diagnosis of HIV-1 infection.

Hashida S, Hirota K, Hashinaka K, Saitoh A, Nakata A, Shinagawa H, Oka S, Shimada K, Mimaya J, Matsushita S, et al.

J Clin Lab Anal. 1993;7(6):353-64.

PMID:
7506305
4.

Diagnostic detection of human immunodeficiency virus type 1 antibodies in urine: a brazilian study.

Oelemann WM, Lowndes CM, Veríssimo Da Costa GC, Morgado MG, Castello-Branco LR, Grinsztejn B, Alary M, Bastos FI.

J Clin Microbiol. 2002 Mar;40(3):881-5.

6.

Performance of two commercial immunochromatographic assays for rapid detection of antibodies specific to human immunodeficiency virus types 1 and 2 in serum and urine samples in a rural community-based research setting (Rakai, Uganda).

Kagulire SC, Stamper PD, Opendi P, Nakavuma JL, Mills LA, Makumbi F, Gray RH, Serwadda D, Reynolds SJ.

Clin Vaccine Immunol. 2007 Jun;14(6):738-40. Epub 2007 Apr 11.

7.

Screening for human immunodeficiency virus antibody in urine.

Berrios DC, Avins AL, Haynes-Sanstad K, Eversley R, Woods WJ.

Arch Pathol Lab Med. 1995 Feb;119(2):139-41.

PMID:
7848060
8.

Evaluation of a commercial enzyme immunoassay for HIV screening in urine.

Almeda J, Casabona J, Matas L, González V, Muga R, Sanz B, Bolao F, Ausina V.

Eur J Clin Microbiol Infect Dis. 2004 Nov;23(11):831-5. Epub 2004 Oct 8.

PMID:
15480885
9.

Urine antibody tests: new insights into the dynamics of HIV-1 infection.

Urnovitz HB, Sturge JC, Gottfried TD, Murphy WH.

Clin Chem. 1999 Sep;45(9):1602-13.

10.

[Study on the indeterminate results of characterization and verification of HIV antibody from Western blot test].

Bao ZY, Liu YJ, Wang HY, Wang QL, Luo Q, Liu YD, Ma F, Xing YC, Tong YG, Li JY.

Zhonghua Liu Xing Bing Xue Za Zhi. 2008 May;29(5):478-81. Chinese.

PMID:
18956682
11.

Human immunodeficiency virus antibody testing by enzyme-linked fluorescent and western blot assays using serum, gingival-crevicular transudate, and urine samples.

Martínez PM, Torres AR, Ortiz de Lejarazu R, Montoya A, Martín JF, Eiros JM.

J Clin Microbiol. 1999 Apr;37(4):1100-6.

12.

Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.

Busch MP, Kleinman SH, Williams AE, Smith JW, Ownby HE, Laycock ME, Lee LL, Pau CP, Schreiber GB.

Transfusion. 1996 Jan;36(1):37-44.

PMID:
8607151
14.

Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot.

Jackson JB, Hanson MR, Johnson GM, Spahlinger TG, Polesky HF, Bowman RJ.

Transfusion. 1995 Feb;35(2):98-102.

PMID:
7825219
15.

Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.

Cooper CJ, Metch B, Dragavon J, Coombs RW, Baden LR; NIAID HIV Vaccine Trials Network (HVTN) Vaccine-Induced Seropositivity (VISP) Task Force.

JAMA. 2010 Jul 21;304(3):275-83. doi: 10.1001/jama.2010.926.

16.

Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.

Torian LV, Forgione LA, Punsalang AE, Pirillo RE, Oleszko WR.

J Clin Virol. 2011 Dec;52 Suppl 1:S41-4. doi: 10.1016/j.jcv.2011.09.017. Epub 2011 Oct 12.

PMID:
21995935
17.

Agreement study between two laboratories of immunofluorescence as a confirmatory test for human immunodeficiency virus type 1 antibody screening.

Mahony J, Rosenthal K, Chernesky M, Castriciano S, Scheid E, Blajchman M, Harnish D.

J Clin Microbiol. 1989 Jun;27(6):1234-7.

18.

Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group.

Gallo D, George JR, Fitchen JH, Goldstein AS, Hindahl MS.

JAMA. 1997 Jan 15;277(3):254-8. Erratum in: JAMA 1997 Mar 12;227(10):792.

PMID:
9005276
19.

The pattern of indeterminate human immunodeficiency virus test and follow-up evaluation in pregnant women.

Jain S, Basraon S, Loeffelholz MJ, Patel JA.

Am J Perinatol. 2011 Jun;28(6):467-72. doi: 10.1055/s-0030-1270114. Epub 2010 Dec 6.

PMID:
21136348
20.

Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.

Keefer MC, Graham BS, Belshe RB, Schwartz D, Corey L, Bolognesi DP, Stablein DM, Montefiori DC, McElrath MJ, Clements ML, et al.

AIDS Res Hum Retroviruses. 1994 Dec;10(12):1713-23.

PMID:
7888231

Supplemental Content

Support Center